XO Life among the leading startups in the European digital health market

Financing of healthcare technologies in Europe has once again reached historic levels, with artificial intelligence driving a new wave of growth in digital care and digital pharmacy. AlbionVC is now presenting the new report on the European healthtech market, which includes 998 companies from the digital pharmaceutical and digital care sectors. The card focuses on companies that were founded in 2015 or later, have received institutional funding in the last three years and employ more than 10 people. XO Life is one of the leading companies in its sector.
Would you like to find out more or are you interested in XO Life?
Get in touch now, get a demo or answer individual questions in a personal conversation.
Discover even more news

Ardeypharm and XO Life: brite™ platform enables digital support for Mutaflor®

XO Life expands internationally - ImpactMonitor™ becomes brite™
